StrategIQ Financial Group, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
101 E 90TH DRIVE MERRILLVILLE, IN 46410
As of the latest 13F report, the guru’s equity portfolio contained 277 stocks valued at a total of $863.00Mil. The top holdings were ECL(10.60%), VTI(3.66%), and SPY(3.31%).
According to GuruFocus data, these were StrategIQ Financial Group, LLC’s top five trades of the quarter.
Vanguard Short-Term Corporate Bond ETF
During the quarter, StrategIQ Financial Group, LLC bought 111,326 shares of NAS:VCSH for a total holding of 369,999. The trade had a 1.05% impact on the equity portfolio. During the quarter, the stock traded for an average price of $75.92.
On 01/13/2023, Vanguard Short-Term Corporate Bond ETF traded for a price of $76.14 per share and a market cap of $41.18Bil. The stock has returned -3.98% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
AbbVie Inc
StrategIQ Financial Group, LLC reduced their investment in NYSE:ABBV by 19,120 shares. The trade had a 0.36% impact on the equity portfolio. During the quarter, the stock traded for an average price of $143.5.
On 01/13/2023, AbbVie Inc traded for a price of $152.89 per share and a market cap of $270.37Bil. The stock has returned 18.54% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, AbbVie Inc has a price-earnings ratio of 20.41, a price-book ratio of 16.91, a price-earnings-to-growth (PEG) ratio of 1.43, a EV-to-Ebitda ratio of 12.91 and a price-sales ratio of 4.84.
The price-to-GF Value ratio is 1.15, earning the stock a GF Value rank of 1.
iShares 0-5 Year TIPS Bond ETF
During the quarter, StrategIQ Financial Group, LLC bought 26,194 shares of ARCA:STIP for a total holding of 38,839. The trade had a 0.32% impact on the equity portfolio. During the quarter, the stock traded for an average price of $99.03.
On 01/13/2023, iShares 0-5 Year TIPS Bond ETF traded for a price of $97.665 per share and a market cap of $13.09Bil. The stock has returned -1.82% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Abbott Laboratories
StrategIQ Financial Group, LLC reduced their investment in NYSE:ABT by 19,614 shares. The trade had a 0.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $106.59.
On 01/13/2023, Abbott Laboratories traded for a price of $113.18 per share and a market cap of $197.09Bil. The stock has returned -11.64% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Abbott Laboratories has a price-earnings ratio of 25.52, a price-book ratio of 5.52, a price-earnings-to-growth (PEG) ratio of 1.17, a EV-to-Ebitda ratio of 15.25 and a price-sales ratio of 4.46.
The price-to-GF Value ratio is 0.88, earning the stock a GF Value rank of 7.
iShares Russell 2000 ETF
During the quarter, StrategIQ Financial Group, LLC bought 11,536 shares of ARCA:IWM for a total holding of 47,711. The trade had a 0.24% impact on the equity portfolio. During the quarter, the stock traded for an average price of $181.52.
On 01/13/2023, iShares Russell 2000 ETF traded for a price of $185.75 per share and a market cap of $54.36Bil. The stock has returned -12.17% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Russell 2000 ETF has a price-earnings ratio of 11.59 and a price-book ratio of 1.98.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
